Anaphylaxis

ASCIA Action Plans and First Aid Plans 2021This webpage includes links to:

Anaphylaxis is a potentially life threatening, severe allergic reaction that requires immediate treatment with adrenaline (epinephrine). Anaphylaxis should always be treated as a medical emergency. Phone ambulance (000-AU or 111- NZ), immediately after giving adrenaline.

ASCIA Action Plans do not expire, and therefore the plan is still valid beyond the review date, which is a guide for patients to see their doctor. Current ASCIA Action Plans are the 2021 versions, however, the 2020 and 2018 versions are still valid for use in 2022.

Action Plans, Forms and Checklists
Allergic Reactions Clinical History Form New April 2020 (with type in fields and tick boxes)
Allergic Reactions Event Record Updated April 2020 (with type in fields and tick boxes)
Anaphylaxis Checklist for Patients Updated September 2021
Adrenaline (Epinephrine) Injector information
Adrenaline Injectors FAQ Updated February 2022
 
Anaphylaxis Guidelines
 
ASCIA anaphylaxis e-training courses
Translations of anaphylaxis information 

Anaphylaxis Patient Information - English Updated September 2021
Anaphylaxis Patient Information - Other Languages
Anaphylaxis Patient Information - Maori, Samoan, Tongan  
First Aid for Anaphylaxis - English Updated September 2021
First Aid for Anaphylaxis - Other Languages 
First Aid for Anaphylaxis - Maori, Samoan, Tongan 
Anaphylaxis Fact Sheet for Parents - English and Other Languages  
Anaphylaxis Fact Sheet for Parents - Maori, Samoan, Tongan 
How to give EpiPen - English and Other Languages 
How to give EpiPen - Maori, Samoan, Tongan 

Translations of chef cards are available from the Allergy & Anaphylaxis Australia website 
 
Translations of asthma action plans are available from the National Asthma Council website
General allergy and anaphylaxis information

Other health professional information is available here: www.allergy.org.au/hp/papers

Information for patients and carers is available here: www.allergy.org.au/patients/information 

Patient and carer support organisations are listed here: www.allergy.org.au/patients/patient-support-organisations

Content updated August 2022 

Mod ASCIA Member
Donate to AIFA
go to NAS website
ASCIA Member Login
ASCIA Update

Information for the community about allergic diseases, immunodeficiencies and other immune diseases.
See latest edition here...
Join our mailing list:
ASCIA News
About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditiation

healthdirect

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.